Esg Planning Merck & Co., Inc. Transaction History

Esg Planning

$151 Million
Q3 2024

A detailed history of Esg Planning transactions in Merck & Co., Inc. stock. As of the latest transaction made, Esg Planning holds 25,397 shares of MRK stock, worth $2.54 Million. This represents 1.91% of its overall portfolio holdings.

Number of Shares

25,397

Previous 19,804 28.24%

Holding current value

$2.54 Million

Previous $2.45 Million 17.67%

% of portfolio

1.91%

Previous 2.46%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	BUY	$111.15 - $128.97 $621,661 - $721,329	5,593 Added 28.24%	25,397 $2.88 Million
Q2 2024 Jul 30, 2024	BUY	$123.8 - $132.96 $1.35 Million - $1.45 Million	10,872 Added 121.72%	19,804 $2.45 Million
Q1 2024 May 01, 2024	BUY	$113.24 - $131.95 $590,773 - $688,383	5,217 Added 140.43%	8,932 $1.18 Million
Q4 2023 Jan 31, 2024	SELL	$100.18 - $109.02 $5,409 - $5,887	-54 Reduced 1.43%	3,715 $405,000
Q3 2023 Nov 01, 2023	BUY	$102.95 - $114.33 $82,874 - $92,035	805 Added 27.16%	3,769 $388,000
Q2 2023 Aug 08, 2023	SELL	$108.61 - $118.38 $364,929 - $397,756	-3,360 Reduced 53.13%	2,964 $342,000
Q1 2023 Apr 26, 2023	SELL	$102.94 - $114.86 $1.36 Million - $1.52 Million	-13,251 Reduced 67.69%	6,324 $672,000
Q4 2022 Feb 03, 2023	SELL	$87.44 - $112.11 $2.43 Million - $3.12 Million	-27,819 Reduced 58.7%	19,575 $2.17 Million
Q3 2022 Nov 09, 2022	BUY	$84.53 - $94.96 $233,302 - $262,089	2,760 Added 6.18%	47,394 $4.08 Million
Q2 2022 Aug 10, 2022	SELL	$83.49 - $94.64 $561,804 - $636,832	-6,729 Reduced 13.1%	44,634 $4.07 Million
Q1 2022 May 31, 2022	BUY	$73.51 - $82.4 $3.78 Million - $4.23 Million	51,363 New	51,363 $4.21 Million

Others Institutions Holding MRK

# of Institutions

3,827

Shares Held

1.87B

Call Options Held

15.6M

Put Options Held

13.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $253B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Esg Planning, based on Form 13F filings with the SEC.

News

Stay updated on Esg Planning with notifications on news.

Account